When lab medicine digs into the depths of big data, amazing things can happen: Catalan researchers are about to predict comorbidities for lung patients based on huge datasets. Early detection is also key for sepsis and myocardial infarction survival – Professor Jeannine T Holden and Dr Tommaso Fasano talk about how rapid indicators can improve the odds.
Advertisement |
 |
Article • Risk assessmentPredictive potential of Big Data in the labBig Data can be a critical tool in helping clinicians develop advanced patient health risk assessment and stratification models as well as leading to a new level of patient empowerment. Professor Josep Roca outlined the benefits of Big Data in a ... |
 |
Sponsored • HematologyEarly sepsis indicator helps identifying patients at riskThe critical element of testing for sepsis lies not so much in the location but in the timing and rapidity of results, according to Professor Jeannine T. Holden from Beckman Coulter Early identification enables treatment protocols to be delivered ... |
 |
Sponsored • SysmexWith the UN-Series, the choice is yoursUsing urine to obtain diagnostic insights has been done for thousands of years and still remains an important tool to obtain crucial information. Covering a range of tests, urinalysis may be used to screen for or help to diagnose ailments such as ... |
 |
Article • Point-of-Care TestingPOCT: A coordination office is necessaryPoint-of-care testing (POCT) is complex and its development continues due to digitisation in healthcare and increasing international partnerships among the healthcare actors. In a hospital, a number of factors need consideration to fully exploit the ... |
 |
Sponsored • Beyond ecomicsHow Axonlab puts social responsibility into practiceSince the firm was created almost 30 years ago, Roland Steger, the founder and CEO of Axon Lab AG, always regarded it as important for it to help resolve social challenges as well as achieving commercial success: “It was always clear to me that a ... |
 |
Article • Improvement of cardiac careRapid myocardial infarction verificationThe use of troponin assays to rule in or rule out myocardial infarction (MI) rapidly is critical on several levels. The quick result can reassure the patient that they have not had a heart attack and can return home safely; or, in the event of MI, ... |
You are receiving this email because you subscribed to our newsletter on healthcare-in-europe If you don’t want to receive this newsletter anymore, click here to unsubscribe. Keep up-to-date on the latest news from all hospital-related fields! Copyright © 2024 mgo fachverlage GmbH & Co. KG. E.-C.-Baumann-Straße 5, 95326 Kulmbach, Germany |
   |